Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829387 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for Diabetic Neuropathic Pain
A NA study, sponsored by VA Connecticut Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT00829387: Completed NA study, sponsored by VA Connecticut Healthcare System.
NCT00829387 is a NA study that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00829387, a NA study, has completed, sponsored by VA Connecticut Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of a brief psychological intervention, cognitive-behavior therapy, for the management of persistent pain associated with diabetic peripheral neuropathic pain.
Primary Outcome
Primary outcome is the estimated mean change in pain intensity ratings from baseline to 12 weeks post-baseline comparing CBT and Educational arms Average pain intensity rating over the last 7 days; 0 (no pain at all) to 10 (worst pain imaginable). The higher the score, the more perceived pain a participant reported.
Interventions
- BEHAVIORAL CBT plus standard pharmaceutical care (CBT/SC)
- BEHAVIORAL Diabetic Education plus standard pharmaceutical care (ED/SC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT00829387 record still lists
NCT00829387 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which CBT plus standard pharmaceutical care (CBT/SC) is the first listed.
NCT00829387 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00829387 about?
NCT00829387 is a clinical study titled "Cognitive Behavioral Therapy for Diabetic Neuropathic Pain". The purpose of this study is to evaluate the efficacy of a brief psychological intervention, cognitive-behavior therapy, for the management of persistent pain associated with diabetic peripheral neuropathic pain.
What is the current status of trial NCT00829387?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2010-03. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00829387?
The interventions under investigation include: CBT plus standard pharmaceutical care (CBT/SC) (BEHAVIORAL), Diabetic Education plus standard pharmaceutical care (ED/SC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00829387?
This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00829387's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia